News

30 September 2024

Save the date! 15-20 June 2025: Twelfth EDCTP Forum

We are delighted to announce that the Twelfth EDCTP Forum will take place on 15-20 June 2025, at the Kigali Convention Centre in Kigali, Rwanda.…

24 September 2024

Eswatini joins EDCTP Association

EDCTP is pleased to welcome Eswatini on board as the newest member country of the EDCTP Association, bringing the total number of African countries to…

31 July 2024

EDCTP Annual Report 2023: two decades and beyond

Twenty years since its launch, the EDCTP programmes have established a model for how equitable research partnerships should operate. This ‘partnership of equals’ covers both…

25 April 2024

World Malaria Day 2024: Accelerating the development of innovative approaches to end malaria

On this World Malaria Day, under the theme ‘Accelerating the fight against malaria for a more equitable world’ we are reminded that more than 90%…

24 April 2024

Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria

Positive data from the phase II/III CALINA study, part of the EDCTP-funded PAMAfrica consortium, demonstrated that a novel formulation of Coartem® (artemether-lumefantrine) developed for babies…

24 March 2024

World TB Day 2024: Funding innovative research to end TB

On this World TB Day 2024, EDCTP reinforces its commitment to investing in tuberculosis (TB) research and development, an important part of the jigsaw to…

12 March 2024

An innovative and integrated intervention package delivered through the health system could protect infants from HIV

Paediatric HIV infections remain unacceptably high, with UNAIDS estimating 130,000 new cases in 2022, most of which occur during breastfeeding. The widespread implementation of universal…

08 March 2024

International Women’s Day 2024: Investing in women to accelerate progress

This year on International Women’s Day, EDCTP joins the global health community in celebrating diversity and empowerment and underscores its commitment to investing in women…

30 January 2024

World NTD Day 2024: investing to control and eliminate neglected tropical diseases

Global investment into research and development of new products for neglected tropical diseases (NTDs, also known as neglected infectious diseases) is limited and there is…

13 January 2024

African women living with HIV have an effective option to prevent malaria during pregnancy

The combination of two antimalarial drugs (DHA-PPQ) reduces the risk of malaria infection and disease in pregnant women on HIV treatment, according to results from…

20 December 2023

2023 End of the year message from Mr Abdoulie Barry, Acting Executive Director

Dear Colleagues, Partners and Friends, As we look forward to celebrating Christmas and New Year with our families and friends, it is important to highlight…

19 December 2023

Early data shows that the H56:IC31 candidate vaccine did not provide protection against TB recurrence

The Statens Serum Institut (SSI) announced today that they will stop the development of the H56:IC31 tuberculosis (TB) candidate vaccine. The first analyses of data…

15 December 2023

EMA recommends arpraziquantel for treatment of schistosomiasis in preschool-aged children

Today, the Pediatric Praziquantel Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive…

15 December 2023

EMA gives positive opinion of Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of the use of Fexinidazole Winthrop…

06 December 2023

PrEPVacc study reports that experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition

Today, the EDCTP-funded PrEPVacc HIV prevention study has announced that it stopped its experimental vaccine regimens as there is little or no chance of the…